Health Information and Quality Authority (HIQA): Health Technology Assessment (HTA) on C-reactive protein point-of-care testing to guide antibiotic prescribing

In February 2018, the Health Information and Quality Authority (HIQA) commenced work on a health technology assessment (HTA) in relation to C-reactive protein point-of-care testing (CRP POCT). HIQA agreed to undertake the HTA following a formal request from the Lead of the Primary Care Clinical Programme in the Health Service Executive (HSE). The aim of the HTA was to establish the clinical and economic impact of providing point-of-care testing to inform antibiotic prescribing for patients presenting with symptoms of acute respiratory tract infections (RTIs) in primary care. This request was endorsed by the Department of Health and was included in the 2018 HIQA HTA work plan.

Click for Report

Just published – JPIAMR: Strategic Research and Innovation Agenda for Antimicrobial Resistance

The JPIAMR Strategic Research and Innovation Agenda (SRIA) that is published today presents an overview of recent developments and future needs for AMR research. The SRIA outlines six key priority topics within the AMR field: Therapeutics, Diagnostics, Surveillance Transmission, Environment and Interventions, and has defined a set of research objectives within each priority topic. Together, 27 countries has created the SRIA.

The SRIA highlights many important research needs, including:
•The need to address AMR with a holistic One Health approach
•The necessity of including innovation in every aspect of AMR research
•Increased inclusion of Low and Middle Income Countries (LMICs)
•The need for developments incorporating personalised medicine and artificial intelligence.

The SRIA is a prime guiding tool for AMR research prioritisation in investments, research activities and planning for JPIAMR member states and other funding initiatives. It is also one of the most thorough guidelines on AMR research, helping researchers, policy makers, media, educators, health workers and the scientific community to work together on solutions to curb AMR on a global scale.

Click Link: JPIAMR: SRAI

New WHO report calls for urgent action to avert antimicrobial resistance crisis

International organizations unite on critical recommendations to combat drug-resistant infections and prevent staggering number of deaths each year

UN, international agencies and experts today released a groundbreking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.

If no action is taken – warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who released the report – drug-resistant diseases could cause 10 million deaths each year by 2050 and damage to the economy as catastrophic as the 2008-2009 global financial crisis. By 2030, antimicrobial resistance could force up to 24 million people into extreme poverty.

Click on Link for Report: WHO Report

Organizations Join Forces to Create Global Alliance Against Antibiotic Resistance

The U.S.-based Antibacterial Resistance Leadership Group (ARLG), part of the Duke Clinical Research Institute (DCRI) and the University Medical Center (UMC) Utrecht, the managing entity of the COMBACTE (Combatting Bacterial Resistance in Europe) consortium, will work together to solidify a comprehensive global community to combat the threat of antibiotic resistance around the world.

This collaboration is expected to take several forms, including joint design and implementation of clinical research, working meetings at scientific conferences like the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), and IDWeek, cross-entity working groups with diverse functional group participation, clinical trial innovations, data and protocol exchanges, and, contractual, regulatory, and systems harmonization.

Click Link for details: Link

AMS Insight 2019 – Monday 10th June 2019: St James’ Hospital

The Antimicrobial Stewardship Committee of St. James’s Hospital along with Health Service Executive infection specialists wish to invite you to the Irish Antimicrobial Stewardship Conference entitled “AMS InSight”. We have invited local and international speakers to discuss important issues related to antimicrobial stewardship, in hospital and community settings.

Click on link for details: AMS Insight 2019

One Health Report on Antimicrobial Use & Antimicrobial Resistance 2019

Ireland’s first One Health Report on Antimicrobial Use & Antimicrobial Resistance provides a snapshot of the antimicrobial use (AMU) and antimicrobial resistance (AMR) in both humans and food-producing animals in Ireland.

Both the Department of Health and the Department of Agriculture, Food and the Marine have adopted the ‘One Health’ approach to AMR and encourage multidisciplinary collaborative efforts across different sectors such as health, agriculture and the environment to achieve the best health outcomes for people and animals.

This Report is an important step forward as we have now commenced cross sectoral surveillance for AMR which will help identify emerging areas of concern and inform joined up solutions to keep antibiotics working for the future.

Click on Link for Report: Report

Recent updates on gonorrhoea antimicrobial resistance in Ireland

Two reports on gonorrhoea antimicrobial resistance in Ireland have recently been published. Antimicrobial resistance in Neisseria gonorrhoeae (N. gonorrhoeae) is a growing global threat and the World Health Organization (WHO) has warned that gonorrhoea may become untreatable in the future due to antimicrobial resistance, if new antimicrobial drugs do not become available.

Click link for details: Reports

New ReAct Report: When the Drugs Don’t Work – Antibiotic Resistance as a Global Development Problem

2019-02-28

Working antibiotics have given us a huge boost in quality of life over the last nine decades, but their importance and value is overlooked. Antibiotics play a crucial role in many more areas of life than most people imagine. This new report by ReAct and Dag Hammarskjöld Foundation looks at the state of global development when the drugs don’t work and a post-antibiotic era sets in. The report shows how antibiotic resistance is a global development problem by highlighting existing data and people’s experiences.

Click for Report: Report

All Island Diagnostics Conference on Disease Prevention, Infection control and AMR

6th June 2019, Belfast

Overview

The All Island Diagnostics conference is an inspiring event examining the role of both molecular and rapid diagnostics in tackling disease, infection and reducing the impact of antimicrobial resistance within our communities and hospitals. The conference and exhibition will explore how Northern Ireland and Ireland health professionals, academics and industry are driving diagnostics usage within laboratories, pharmacies and community practice.

The conference builds on the UK Diagnostics Summit held annually in London and will discuss how diagnostics are tackling cancer, diabetes, sepsis, urinary tract infections and HAI’S. This is a must attend event, targeted to those who are responsible for managing the smarter delivery of diagnostics services and determining precise diagnosis for their patients.

The event will bring together 150 NHS and HSE diagnostics leaders including service managers and diagnostic consultant medical doctors from across Northern Ireland & Ireland.

Click on link for details All Island Diagnostics Conference